(Q46640095)

English

Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study

scientific article published in January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Cesario D

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

Clark J

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

Maisel A

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

American Heart Journal

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

135

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

121-129

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Tachyphylaxis with amrinone therapy: association with sequestration and down-regulation of lymphocyte beta-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

In vivo regulation of beta-adrenergic receptors on mononuclear leukocytes and heart. Assessment of receptor compartmentation after agonist infusion and acute aortic constriction in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Use of milrinone in cardiac surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Tolerance to dobutamine after a 72 hour continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970352-7

7 January 2021

Identifiers

10.1016/S0002-8703(98)70352-7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/9453531

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46640095&oldid=2123650100"